![]() Music |
![]() Video |
![]() Movies |
![]() Chart |
![]() Show |
![]() |
Evaluating progression in MS (VJNeurology) View |
![]() |
Assessing Neuroimmune Interactions in the Progression and Management of Multiple Sclerosis (NeurologyLive) View |
![]() |
Methods for measuring treatment response and disease progression in MS (VJNeurology) View |
![]() |
Diet quality and clinical progression in MS over 7.5 years of follow-up (VJNeurology) View |
![]() |
Serum biomarkers of brain atrophy in MS (VJNeurology) View |
![]() |
Measuring Outcomes in MS (NeurologyLive) View |
![]() |
Evaluation of sNfL in MS patients with NEDA-3 (VJNeurology) View |
![]() |
Multiple sclerosis - causes, symptoms, diagnosis, treatment, pathology (Osmosis from Elsevier) View |
![]() |
Evaluating Natalizumab’s Risk-Benefit Profile in MS (NeurologyLive) View |
![]() |
Using Brain Connectomes to Predict Disease Progression and Treatment Response in Multiple Sclerosis (NeurologyLive) View |